Harry Mansbach

Harry Mansbach

Directeur Technique/Scientifique/R&D chez 89BIO, INC.
61 ans
Health Technology
Consumer Services
Health Services

Profil

Harry H.
Mansbach
currently works at 89bio, Inc., as Chief Medical Officer from 2018.
Dr. Mansbach also formerly worked at GlaxoSmithKline LLC, as Director-Clinical Development & Neurosciences, Bausch Health Americas, Inc., as Senior VP & Head-Global Drug Development, RespireRx Pharmaceuticals, Inc., as Chief Medical Officer & VP-Clinical Development from 2004 to 2006, Ultragenyx Pharmaceutical, Inc., as Head-Global Clinical Development in 2018, Henry Ford Health System, as Member-Neurology Department, and Medivation LLC (California), as Vice President-Medical Affairs from 2009 to 2015.
Dr. Mansbach received his doctorate degree from Duke University and undergraduate degree from Yale University.

Postes actifs de Harry Mansbach

SociétésPosteDébut
89BIO, INC. Directeur Technique/Scientifique/R&D 01/12/2018

Anciens postes connus de Harry Mansbach

SociétésPosteFin
ULTRAGENYX PHARMACEUTICAL INC. Directeur Technique/Scientifique/R&D 01/12/2018
MEDIVATION INC Directeur Technique/Scientifique/R&D 01/04/2015
RESPIRERX PHARMACEUTICALS INC. Directeur Technique/Scientifique/R&D 15/12/2006
Directeur Technique/Scientifique/R&D -
Corporate Officer/Principal -
Voir l'expérience en détail de Harry Mansbach

Formation de Harry Mansbach

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Harry Mansbach
🔇